424 related articles for article (PubMed ID: 17572354)
1. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers.
Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK
Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354
[TBL] [Abstract][Full Text] [Related]
2. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer.
Agashe HB; Dutta T; Garg M; Jain NK
J Pharm Pharmacol; 2006 Nov; 58(11):1491-8. PubMed ID: 17132212
[TBL] [Abstract][Full Text] [Related]
3. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.
Agrawal P; Gupta U; Jain NK
Biomaterials; 2007 Aug; 28(22):3349-59. PubMed ID: 17459469
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates.
Zhang Y; Sun Y; Xu X; Zhang X; Zhu H; Huang L; Qi Y; Shen YM
J Med Chem; 2010 Apr; 53(8):3262-72. PubMed ID: 20350006
[TBL] [Abstract][Full Text] [Related]
5. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
Mishra V; Jain NK
Int J Pharm; 2014 Jan; 461(1-2):380-90. PubMed ID: 24291772
[TBL] [Abstract][Full Text] [Related]
6. Genotoxicity of poly(propylene imine) dendrimers.
Ziemba B; Matuszko G; Appelhans D; Voit B; Bryszewska M; Klajnert B
Biopolymers; 2012 Aug; 97(8):642-8. PubMed ID: 22605555
[TBL] [Abstract][Full Text] [Related]
7. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells.
Gupta U; Dwivedi SK; Bid HK; Konwar R; Jain NK
Int J Pharm; 2010 Jun; 393(1-2):185-96. PubMed ID: 20382210
[TBL] [Abstract][Full Text] [Related]
8. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer.
Kesharwani P; Tekade RK; Jain NK
Biomaterials; 2014 Jul; 35(21):5539-48. PubMed ID: 24731713
[TBL] [Abstract][Full Text] [Related]
9. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes.
Mishra V; Gupta U; Jain NK
Pharmazie; 2010 Dec; 65(12):891-5. PubMed ID: 21284258
[TBL] [Abstract][Full Text] [Related]
10. Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.
Dutta T; Garg M; Jain NK
Vaccine; 2008 Jun; 26(27-28):3389-94. PubMed ID: 18511160
[TBL] [Abstract][Full Text] [Related]
11. Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates.
Szulc A; Signorelli M; Schiraldi A; Appelhans D; Voit B; Bryszewska M; Klajnert-Maculewicz B; Fessas D
Int J Pharm; 2015 Nov; 495(2):940-7. PubMed ID: 26456295
[TBL] [Abstract][Full Text] [Related]
12. PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist.
Gajbhiye V; Vijayaraj Kumar P; Tekade RK; Jain NK
Eur J Med Chem; 2009 Mar; 44(3):1155-66. PubMed ID: 18760863
[TBL] [Abstract][Full Text] [Related]
13. In vivo toxicity of poly(propyleneimine) dendrimers.
Ziemba B; Janaszewska A; Ciepluch K; Krotewicz M; Fogel WA; Appelhans D; Voit B; Bryszewska M; Klajnert B
J Biomed Mater Res A; 2011 Nov; 99(2):261-8. PubMed ID: 21976451
[TBL] [Abstract][Full Text] [Related]
14. Characterization and evaluation of amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers.
Jain K; Verma AK; Mishra PR; Jain NK
Nanomedicine; 2015 Apr; 11(3):705-13. PubMed ID: 25596078
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration.
Okuda T; Kawakami S; Maeie T; Niidome T; Yamashita F; Hashida M
J Control Release; 2006 Aug; 114(1):69-77. PubMed ID: 16814896
[TBL] [Abstract][Full Text] [Related]
16. Polypropylene imine dendrimer mediated solubility enhancement: effect of pH and functional groups of hydrophobes.
Gupta U; Agashe HB; Jain NK
J Pharm Pharm Sci; 2007; 10(3):358-67. PubMed ID: 17727799
[TBL] [Abstract][Full Text] [Related]
17. Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers.
Kojima C; Regino C; Umeda Y; Kobayashi H; Kono K
Int J Pharm; 2010 Jan; 383(1-2):293-6. PubMed ID: 19761822
[TBL] [Abstract][Full Text] [Related]
18. Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities.
Zhao C; Wang Y; Su Y; Zhang H; Ding L; Yan X; Zhao D; Shao N; Ye X; Cheng Y
Int J Pharm; 2011 Dec; 421(2):301-9. PubMed ID: 22001794
[TBL] [Abstract][Full Text] [Related]
19. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers.
Kaminskas LM; Boyd BJ; Karellas P; Krippner GY; Lessene R; Kelly B; Porter CJ
Mol Pharm; 2008; 5(3):449-63. PubMed ID: 18393438
[TBL] [Abstract][Full Text] [Related]
20. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting.
Bhadra D; Yadav AK; Bhadra S; Jain NK
Int J Pharm; 2005 May; 295(1-2):221-33. PubMed ID: 15848007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
